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Metabolomic profiling provides new 
insights into blood-brain barrier 
regulation
Early blood-brain barrier (BBB) disturbance 
contributes to many different neurological 
diseases including Alzheimer ’s disease, 
Parkinson’s disease and stroke, particularly 
in the etiology and early stages (Abbott 
et al., 2010). Although supporting barrier 
function is a potential strategy to radically 
improve treatment efficacy and disease 
outcome, ways to achieve this objective 
remain elusive. Being a sophisticated system 
consisting of multicellular interactions, better 
understanding of how individual cell-specific 
molecular and metabolic changes modulate 
the unit responses would provide significant 
insight. In this regard, we have generated 
severity-related metabolomic databases 
to reveal fundamental BBB cell-specific 
processes likely to occur physiologically and 
during disease (Huang et al., 2020a). This 
resource provides new opportunities for 
future clinical applications.
The BBB plays a critical role in facilitating 
brain homeostasis (Abbott et al., 2010). It is 
a complex vascular structure composed of 
specialized endothelial cells (ECs) that are 
surrounded by perivascular components 
namely  astrocyte  endfeet ,  per icytes 
and basal membrane (parenchyma and 
endothelia membrane). These compartments 
are intimately linked and interact with 
o n e  a n o t h e r,  re s u l t i n g  i n  a  u n i q u e 
vascular unit. The regulatory mechanisms 
provided by perivascular components 
throughout development and adulthood 
have been mainly described in relation to 
gene signaling, growth factor secretion 
and physical support. However, these 
interactions are interrupted by injury (Abbott 
et al., 2010). The fact that injury-induced 
cell-specific responses correlate with BBB 
impairment (Engelhardt et al., 2015) implies 
intrinsic adaptation versus susceptibility to a 
changing environment is a key determinant 
for whether the associated cells continuously 
support the BBB or only their own survival.
It is now apparent that ECs themselves 
undergo disease-specific modulations as 
well as influence surrounding cells. Our 
study clearly showed that despite severe 
injury conditions, and even in absence of 
other cells, microvascular ECs continuously 
maintain their physiological metabolomic 
barr ier  character ist ics  (Huang et  a l . , 
2020a) rather than activate the adaptive 
mechanisms observed in ECs from other 
vascular beds (Li and Carmeliet, 2018). These 
observations agree with a study showing 
BBB disruption shifts barrier ECs into a 
peripheral ECs-like state that compromises 
brain functions (Munji et al., 2019). Clearly 
maintaining their specific brain features is 
intrinsic and this new data further highlights 
the importance of metabolomic regulation. 
For instance, during energy depletion and 
stress autophagy redistributes metabolic 
resources by liberating required metabolites 
such as amino and fatty acids, sugars, and 
nucleosides. Without autophagic processes 
metabolism is  s lowly shut down. The 
reduced metabolic flexibility of brain ECs 
correlates with the fact that even severe 
oxygen/glucose deprivat ion does not 
activate their autophagy pathway (Engelhardt 
et al., 2015), in contrast to peripheral EC 
alterations (Chen et al., 2013). Peripheral 
ECs also mobilize hypoxia-induced glycolysis 
and other metabolic alterations (Li and 
Carmeliet, 2018), whereas brain EC again 
lack this ability (Huang et al., 2020a). While 
faithfully and continuously protecting brain 
homeostasis, the reluctance or inability of 
brain ECs to metabolically adjust means 
they are increasingly depleted of critical 
metabolites. It seems highly feasible that 
metabolic supplementation to compensate 
reduced resources would support ECs 
demands, improve cell tolerance and extend 
BBB function. 
Looking from the brain side of the BBB, 
understanding the intrinsic metabolic 
contributions of perivascular cells such as 
pericytes and astrocytes could also afford 
substantial gains into ways to modulate 
this complex unit.  The metabolism of 
brain pericytes has undergone only limited 
an a lys i s .  Recent ly,  however,  human 
placental pericytes were shown to be highly 
glycolytic and exhibit distinct proliferative 
and quiescent metabolic characteristics 
(Cantelmo et al., 2016). Indeed, the relevant 
study showed that modulation of pericytic 
metabolism played a key role in tumor vessel 
stability again highlighting the importance of 
metabolic crosstalk in vascular functionality. 
How similar these peripheral pericytes are to 
those in the brain remains an open question. 
Intr iguingly,  hundreds of  genes with 
potentially paracrine-related functions have 
been identified by RNA-seq in rodent capillary 
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pericytes including many SLC, ATP and ABC 
transporter families (Chasseigneaux et al., 
2018), implying significant communication 
may occur through this largely unexplored 
pathway. In contrast, gliovascular modulation 
has received extensive attention, particularly 
on the localized function of AC endfeet as 
local mRNA translation in these processes is 
critical for synapse modulation and neuron 
activity (Boulay et al., 2017). By performing 
cell and ribosome-bound transcriptomics, 
the “endfeetome” generated reveals that 
numerous endfeet-localized mRNAs are 
also BBB related (Boulay et al., 2017). For 
example, connexin 43 is associated with 
BBB immune quiescence and angiotensin 
for BBB maintenance. Furthermore, many 
transporter mRNAs (including organic 
anion and amino acid transporters) are also 
explicitly expressed in astrocyte endfeet 
(Boulay et al., 2017). Clearly signaling 
between perivascular cells (both astrocytes 
and pericytes) and the capillary is more 
than growth factor stimulation or physical 
support but involves complex interaction 
of diverse molecules and metabolites. 
Whereas transcriptomic and proteomic 
data reveal potential cellular phenotypic 
adaptat ions ,  the  metabolome i s  the 
physiological driver that determines overall 
cell behavior. An intriguing study by Maoz 
et al. (2018) demonstrated that the BBB 
proteome and metabolome also modulates 
surrounding neuronal metabolic activity and 
impacts the neurovascular unit (NVU) as a 
whole. Combined mapping of all available 
“omic” data wil l  undoubtedly provide 
unprecedented insights into regulation of the 
intricate BBB and NVU network as a whole.
Which cell initiates metabolic alterations 
at the BBB? It seems intuitive that ECs, 
contacting and responsive to the circulatory 
system, provide the primary signals that 
modulate metabolic activity in perivascular 
ce l l s .  In  agreement,  a  study showed 
that transcriptomic signatures could be 
recapitulated or rejuvenated with acute 
exposure to aged or young mouse plasma 
(Chen et al., 2020), underlining that ECs 
are exquisite sensors of circulatory cues. 
However direct proof that luminal stimulation 
alters ECs behaviors to proactively request 
help from perivascular cells has not been 
shown. As ECs have low metabolic flexibility 
(Engelhardt et al., 2015; Huang et al., 2020a) 
obtaining essential nutrients and support 
from the more adaptable surrounding 
perivascular cells would be clever. Indeed we 
noted that injury-increased abundance of 
key astrocyte metabolites highly correlated 
with  greater  ce l lu lar  to lerance,  and 
generated significant stores. This led us to 
propose that astrocyte metabolic shuttling 
provides essential support for the BBB and 
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NVU as a whole, similar to the extensive 
metabolic cooperation known to exist 
between AC and neurons (Bélanger et al., 
2011). Directionality of astrocyte shuttling 
needs further investigation but we speculate 
secretion will occur from both apical and 
basal sides, i.e. towards both neuronal and 
EC compartments. Whether the level of 
secretion would be identical or different in 
either direction is an intriguing question. 
Indeed astrocytes could be guardians of cells 
in all brain compartments.
Following up on these ideas, screening our 
metabolomic data and applying knowledge 
from previous studies has al lowed us 
to identify beneficial astrocyte-driven 
metabolites that are potentially shuttled to 
ECs. We recently showed that glutathione 
shuttling exists between astrocytes and ECs 
and is crucial for BBB homeostasis (Huang 
et al., 2020b), underlining that depletion of 
a single metabolite can modulate vascular 
function. With regards to pericytes, a similar 
conclusion can also be inferred from the 
above mentioned cancer study (Cantelmo 
et al., 2016). Thus, exploitation of intrinsic 
metabol ic-dr iven BBB regulat ion wi l l 
undoubtedly provide novel ways to influence 
brain homeostasis. Above all, these key 
factors could potentially be “customized” 
according to different diseases - a concept 
supported by Nolan et al.  (2013) who 
suggested distinct angiocrine responses 
from different ECs likely correlate with their 
specialized metabolic demands. Indeed, 
targeting EC metabolism has been proposed 
as a new therapeutic opportunity for drug 
delivery and functional vascular modulation 
in cancer treatment (Li and Carmeliet, 2018). 
Applying a similar strategy could surely 
facilitate BBB modulation.
BBB researchers frequently use in vitro 
systems to answer complex questions. 
Our studies, and that of Maoz et al. (2018) 
using a linked organ-on-chip model, utilize 
simplified and multicellular culture systems 
to reveal basic individual cell responses 
and/or paracel lular  cross-talk  during 
environmental change, giving extensive 
insight into adaptation and interactions likely 
to occur at the BBB in vivo. Now we need to 
build on this knowledge. Combining novel 
spatial omics with 3D spheroid/organoid 
disease models more reminiscent of the in 
vivo situation, isolated microvessels and/or 
brain tissue sections will provide more in-
depth information. Particularly untargeted 
spatial metabolomics coupling technologies, 
such as matrix-assisted laser desorption/
ionization enables metabolites, lipids, and 
drugs in tissue sections to be localized 
providing information of cell metabolic 
behavior and drug metabolism while cells 
are in contact. These will provide significant 
insight with the caveats that only a snapshot 
of the metabolic state at a given point in 
time is gained and the resolution obtained 
is still insufficient to observe paracellular 
shuttling. It is clear that further technological 
advances will be the key as the data we have 
presented (Huang et al., 2020a) suggests the 
EC drive for homeostasis will make assigning 
metabolic responses to individual cells even 
in multicellular in vitro models difficult, talk 
less of the in vivo situation.
In conclusion, we have demonstrated 
that cells of the BBB exhibit differential 
metabolomic profiles during resting and 
injury conditions that modulate both their 
own behavior and those of surrounding 
cells. This metabolomic resource clearly 
lays  important  foundat ions  to  more 
fully understand BBB maintenance and 
regulation. Indeed better understanding of 
EC metabolic demands and management 
holds much promise to support barrier 
health and advance treatment strategies for 
neuroprotection and drug delivery.  
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